ID LCTA_LATTR Reviewed; 1413 AA. AC Q9XZC0; DT 16-JAN-2004, integrated into UniProtKB/Swiss-Prot. DT 09-FEB-2010, sequence version 2. DT 02-SEP-2026, entry version 94. DE RecName: Full=Alpha-latrocrustotoxin-Lt1a {ECO:0000305}; DE Short=Alpha-LCT-Lt1a {ECO:0000305}; DE AltName: Full=Alpha-latrocrustotoxin {ECO:0000303|PubMed:34845192}; DE Short=Alpha-LCT {ECO:0000303|PubMed:34845192}; DE AltName: Full=Crusta1; DE Flags: Precursor; Fragment; OS Latrodectus tredecimguttatus (Mediterranean black widow spider) OS (Latrodectus mactans tredecimguttatus). OC Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida; Araneae; OC Araneomorphae; Entelegynae; Araneoidea; Theridiidae; Latrodectus. OX NCBI_TaxID=6925; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=10563207; RA Danilevich V.N., Luk'ianov S.A., Grishin E.V.; RT "Cloning and structure of gene encoded alpha-latrocrustoxin from the Black RT widow spider venom."; RL Bioorg. Khim. 25:537-547(1999). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=11195592; DOI=10.1023/a:1026666606311; RA Danilevich V.N., Grishin E.V.; RT "The chromosomal genes for black widow spider neurotoxins do not contain RT introns."; RL Bioorg. Khim. 26:933-939(2000). RN [3] RP PARTIAL NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Venom gland; RX PubMed=10234443; RA Volynskii K.E., Volkova T.M., Galkina T.G., Krasnoperov V.G., RA Pluzhnikov K.A., Khvoshchev M.V., Grishin E.V.; RT "Molecular cloning and primary structure of cDNA fragment for alpha- RT latrocrustatoxin from black widow spider venom."; RL Bioorg. Khim. 25:25-30(1999). RN [4] RP TOXIC DOSE. RX PubMed=9792186; DOI=10.1016/s0041-0101(98)00162-7; RA Grishin E.V.; RT "Black widow spider toxins: the present and the future."; RL Toxicon 36:1693-1701(1998). RN [5] RP STRUCTURE BY ELECTRON MICROSCOPY (4.03 ANGSTROMS) OF 48-1066 IN MONOMERIC RP FORM, FUNCTION, RECOMBINANT EXPRESSION, AND SUBUNIT. RX PubMed=34845192; DOI=10.1038/s41467-021-26562-8; RA Chen M., Blum D., Engelhard L., Raunser S., Wagner R., Gatsogiannis C.; RT "Molecular architecture of black widow spider neurotoxins."; RL Nat. Commun. 12:6956-6956(2021). CC -!- FUNCTION: Crustacean-selective presynaptic neurotoxin that induces CC neurotransmitter exocytosis. May bind to crustacean neurexin-1 homolog, CC adhesion G protein-coupled receptor L1 homolog, and receptor-type CC tyrosine-protein phosphatase S homolog, and induces neurotransmitter CC exocytosis both by forming tetrameric pores in membranes and signaling CC via G protein-coupled receptor (By similarity) (PubMed:34845192). This CC recombinant protein form channels in artificial membrane bilayers, that CC are stabilized by calcium ions and allow calcium flux at negative CC membrane potentials (PubMed:34845192). {ECO:0000250|UniProtKB:P23631, CC ECO:0000269|PubMed:34845192}. CC -!- SUBUNIT: Homotetramer in membranes. {ECO:0000269|PubMed:34845192}. CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305|PubMed:10234443}. Target CC cell membrane {ECO:0000269|PubMed:34845192}. Note=Forms a membrane CC channel in the prey. {ECO:0000269|PubMed:34845192}. CC -!- TISSUE SPECIFICITY: Expressed by the venom gland. CC {ECO:0000305|PubMed:10234443}. CC -!- DOMAIN: The H8 helix is predicted to insert into membranes and form CC pores by assembling into tetramers. The helix is contained within a CC helical bundle domain that undergoes significant conformational changes CC during pore formation to allow exposure of the H8 transmembrane helix CC and transition of the toxin from a soluble monomer to a transmembrane CC tetramer. {ECO:0000269|PubMed:34845192}. CC -!- TOXIC DOSE: LD(50) is 100 ug/kg to the crayfish Procambarus cubensis. CC {ECO:0000269|PubMed:9792186}. CC -!- SIMILARITY: Belongs to the cationic peptide 01 (latrotoxin) family. 01 CC (alpha-latrocrustotoxin) subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF134162; AAD33043.1; -; Genomic_DNA. DR PDB; 7PTX; EM; 4.03 A; A=16-1211. DR AlphaFoldDB; Q9XZC0; -. DR EMDB; EMD-13642; -. DR SMR; Q9XZC0; -. DR ArachnoServer; AS000061; alpha-Latrocrustotoxin-Lt1a. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. DR Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 5. DR InterPro; IPR002110; Ankyrin_rpt. DR InterPro; IPR036770; Ankyrin_rpt-contain_sf. DR PANTHER; PTHR24161; ANK_REP_REGION DOMAIN-CONTAINING PROTEIN-RELATED; 1. DR PANTHER; PTHR24161:SF85; PALMITOYLTRANSFERASE HIP14; 1. DR Pfam; PF00023; Ank; 1. DR Pfam; PF12796; Ank_2; 6. DR PRINTS; PR01415; ANKYRIN. DR SMART; SM00248; ANK; 20. DR SUPFAM; SSF48403; Ankyrin repeat; 3. DR PROSITE; PS50297; ANK_REP_REGION; 1. DR PROSITE; PS50088; ANK_REPEAT; 12. DR PDBsum; 7PTX; -. PE 1: Evidence at protein level; KW 3D-structure; ANK repeat; Cleavage on pair of basic residues; Exocytosis; KW Membrane; Neurotoxin; Presynaptic neurotoxin; Repeat; Secreted; KW Target cell membrane; Target membrane; Toxin; Transmembrane. FT PROPEP <1..28 FT /evidence="ECO:0000305" FT /id="PRO_0000391353" FT CHAIN 29..1192 FT /note="Alpha-latrocrustotoxin-Lt1a" FT /evidence="ECO:0000305" FT /id="PRO_0000067053" FT PROPEP 1193..1413 FT /evidence="ECO:0000305" FT /id="PRO_0000391354" FT REPEAT 457..490 FT /note="ANK 1" FT /evidence="ECO:0000255" FT REPEAT 494..524 FT /note="ANK 2" FT /evidence="ECO:0000255" FT REPEAT 528..557 FT /note="ANK 3" FT /evidence="ECO:0000255" FT REPEAT 562..592 FT /note="ANK 4" FT /evidence="ECO:0000255" FT REPEAT 596..625 FT /note="ANK 5" FT /evidence="ECO:0000255" FT REPEAT 629..658 FT /note="ANK 6" FT /evidence="ECO:0000255" FT REPEAT 664..694 FT /note="ANK 7" FT /evidence="ECO:0000255" FT REPEAT 699..729 FT /note="ANK 8" FT /evidence="ECO:0000255" FT REPEAT 733..762 FT /note="ANK 9" FT /evidence="ECO:0000255" FT REPEAT 766..795 FT /note="ANK 10" FT /evidence="ECO:0000255" FT REPEAT 799..828 FT /note="ANK 11" FT /evidence="ECO:0000255" FT REPEAT 832..861 FT /note="ANK 12" FT /evidence="ECO:0000255" FT REPEAT 866..895 FT /note="ANK 13" FT /evidence="ECO:0000255" FT REPEAT 899..928 FT /note="ANK 14" FT /evidence="ECO:0000255" FT REPEAT 965..995 FT /note="ANK 15" FT /evidence="ECO:0000255" FT REPEAT 996..1026 FT /note="ANK 16" FT /evidence="ECO:0000255" FT REPEAT 1031..1072 FT /note="ANK 17" FT /evidence="ECO:0000255" FT REPEAT 1077..1106 FT /note="ANK 18" FT /evidence="ECO:0000255" FT REPEAT 1109..1139 FT /note="ANK 19" FT /evidence="ECO:0000255" FT REPEAT 1143..1172 FT /note="ANK 20" FT /evidence="ECO:0000255" FT REGION 238..257 FT /note="Helix H8 is the probable transmembrane region of the FT tetrameric pore inserted in the target cell membrane" FT /evidence="ECO:0000305|PubMed:34845192" FT NON_TER 1 SQ SEQUENCE 1413 AA; 158223 MW; 98E263D6CE982EC8 CRC64; VSIFIFHFSA NILVRNSEMK GKRVISKREM SKADQCTFLS YQSVAYGTLG DVAGDVSSIE GADLVATPIA AGGHLAKGAT DAAMIAMDCS SIPFDEIKQQ LNQRFNEVDK KLQKGAEALE NVTELAEKTY SSVEKMRVEM REGFNHVIAT IENANTKQII TGINQIIQYF NDERENINNR QKEDYVAKLQ EPASGNFLLY LRKSRTSEDG SLHSLLFKII NQELAIPNNA ADNNAIRALF ALFYGTQTFI SIMFYLVKQY SYLADYHYQN GNLAEFNSNF DHMKTVFQDF KFTLIGINTS NSKPLVNTVL SIIEDVKNKR FIRNLRSNLY QKIIKSTKSL LDLREKITKM DLPIIEDTPK SSVLINFREK SSSVPRIETP ILKWTPGTVV KYAIQYEQDG KYSKISKWSN PITVQRLANP YITIDKDRRN RLVFRQFGNE KPELISILDS SQNEFRDIHR DLYNAAQMPY KETALGICRK LIDSGAQVGA SFEMGRKSIH ASATAGNDDV ARLLLAKNNG LLNVPDKNGY TPLHIASERK NNDFVKFLLE KGADVNVRTF ANELTPLHLA ARQDFTIIVK TLMEKRGIDV NAKERAGFTP LHLSITSNSR AARTLINETP AGINIKSNSG LTPLHLAVLQ NNLSAAKVLV KSNKKVKLNE MDNNGMTPLH YASMLGNLEF VKYFTSEQGI DVNAKTKVKN WTPLHLAILF KKFDVAQSLL QVRNIDISTR ADQAITPLHL AAATGNSQIV KTILNSGAVV DQETANGFTA LHLAIMNPNT ETPQFLIAKG ANINAKTNDG STPLHFAAAL GKTNIFQLLM DKGANIKAEN LINQMPIHEA VVNGHLAIVK MLIEQDSSLM NAKNMRDEYP FYLAAEKRYK DVFNYLESKG ADVNEKNNDG NTLLHLFSIN GEVEVVQFLI QNGADFRLRN KERKSFFDLA VEFGHAGIVG YAIEENKVDL QEPYRGKTIL YHAICDSVKY DRIEVVRYFV ETLNEDQCSP LQEAAAYAHL DLVKYFVQER GINPTAFNND NQVSPLCIAI VGAPCGFVKS CDTPERLDVV EYLVDKTPDI NKECDTQQST PVSSAVYGNK VSILNYLIRN GADPNKKVRG DPPLFIAAMI GQYDIVKSLV EQHKIDVNTR NKEQFTPLHA AASNDHIDVV KYLIQKGADV NAKGDENLKP IDLAGEKSKA YLRSLGRRFF RNESPSKSFE IDKFNAIMPE VSMSGKVSHD SNFIQHISSG TRSKSNFNSA KNKMYAENSH VRSIDVNGAL LLLDFMVRVF SNRKMNYAAS ISGIKSRSNS EAQAEALILT ERFEHLLNAL IADQSIDSLD FSNVHSRIYK AIINGNPNGI SEMLCSYAKE YSELDPEKIE KLLQEFETLT FTKSSEIQIN EKFSHALFET CGLNRPTNVL QIK //